Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BEKE-W
02423
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Operating cash flow (direct method) | ||||
| Cash income from operating activities | 12.74%1.05B | 2.14%933.85M | 32.08%914.27M | 692.21M |
| Revenue from customers | 12.74%1.05B | 2.14%933.85M | 32.08%914.27M | --692.21M |
| Cash paid | -9.92%-992.27M | -1.69%-902.73M | -25.33%-887.77M | -708.37M |
| Payments to suppliers for goods and services | -9.92%-992.27M | -1.69%-902.73M | -25.33%-887.77M | ---708.37M |
| Direct interest paid | 13.65%-1.18M | 4.69%-1.36M | -154.00%-1.43M | ---563K |
| Direct interest received | 35.25%4.55M | 45.38%3.37M | 1,018.84%2.32M | --207K |
| Direct tax refund paid | -244.46%-10.75M | 18.36%-3.12M | 6.11%-3.82M | ---4.07M |
| Operating cash flow | 77.24%53.17M | 27.35%30M | 214.39%23.56M | ---20.59M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | 62.05%-11.5M | -1,211.73%-30.31M | 82.98%-2.31M | -13.58M |
| Net PPE purchase and sale | -33.22%-1.94M | 29.59%-1.45M | 52.30%-2.07M | ---4.33M |
| Net intangibles purchas and sale | 96.07%-17K | -14,333.33%-433K | 99.22%-3K | ---384K |
| Net business purchase and sale | ---- | ---- | ---- | ---8.87M |
| Net investment purchase and sale | 66.41%-9.55M | -57,914.29%-28.43M | ---49K | ---- |
| Net other investing changes | ---- | ---- | ---194K | ---- |
| Cash from discontinued investing activities | ||||
| Investing cash flow | 62.05%-11.5M | -1,211.73%-30.31M | 82.98%-2.31M | ---13.58M |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | -7.00%-21.79M | -60.04%-20.37M | -1,300.47%-12.73M | 1.06M |
| Net issuance payments of debt | ---- | 0.00%-5.35M | -150.00%-5.35M | --10.7M |
| Net common stock issuance | -265.53%-3.53M | -355.56%-966K | -80.05%378K | --1.9M |
| Cash dividends paid | -29.75%-15.71M | -107.33%-12.11M | 28.96%-5.84M | ---8.22M |
| Net other financing activities | 34.33%-2.55M | -1.52%-3.89M | 42.28%-3.83M | ---6.63M |
| Cash from discontinued financing activities | ||||
| Financing cash flow | -7.00%-21.79M | -60.04%-20.37M | -1,300.47%-12.73M | --1.06M |
| Net cash flow | ||||
| Beginning cash position | -22.84%69.87M | 10.39%90.55M | -28.76%82.03M | --115.15M |
| Current changes in cash | 196.13%19.88M | -342.67%-20.68M | 125.73%8.52M | ---33.12M |
| End cash Position | 28.45%89.75M | -22.84%69.87M | 10.39%90.55M | --82.03M |
| Free cash from | 82.58%51.22M | 30.74%28.05M | 184.79%21.46M | ---25.31M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |